Search
Researchers at The Kids Research Institute Australia have discovered a new drug combination that could help improve survival rates for babies with leukaemia.
In this. i study the MTD and RP2D, safety, PK, and preliminary activity of single-agent ribociclib were investigated in patients with neuroblastoma.
This study defines PFS and OS, and is the first describe post-progression survival in a large cohort of children with DIPG.
Mental health benefits of a pedometer-based exercise intervention for parents of children with cancer were identified.
In this study, we investigate the in vivo synergy between romidepsin and cytarabine
Our findings shed light on the mechanisms of leukemia-induced bone loss
We found two known risk factors in a large cohort of children treated for ALL and identified other factors associated with venous thromboembolism
Our results show that TRM cells have a fundamental role in the surveillance of subclinical melanomas in the skin by maintaining cancer-immune equilibrium
This JAK3A572V knockin model is a relevant new tool for testing the efficacy of JAK inhibitors in JAK3-related hematopoietic malignancies
Risk of childhood acute lymphoblastic leukaemia following parental occupational exposure to extremely low frequency electromagnetic fields British Journal..